Peripheral Blood Stem Cell Transplantation Completed Phase 1 Trials for Sirolimus (DB00877)

IndicationStatusPhase
DBCOND0038647 (Peripheral Blood Stem Cell Transplantation)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00670423A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) TransplantationTreatment